1-4 of 4
Maximiliano Riddick
Close
Sort by
Journal Articles

Impact of Ibrutinib in Quality of Life (QoL) in Patients with Chronic Lymphocytic Leukemia(CLL): Real World Experience in Argentina

María Jose Mela Osorio, Astrid Pavlovsky, Carolina Pavlovsky, Isolda I Fernandez, Manuela Clavijo, Augusto Miroli, Federico Sackmann, Guillermina Remaggi, Luciana C Ferrari, Mariana Juni, Carolina Sighel, Maximiliano Riddick, Miguel Arturo Pavlovsky
Journal: Blood
Blood (2022) 140 (Supplement 1): 12403–12404.
https://doi.org/10.1182/blood-2022-165626
Published: 2022
Journal Articles

High Level of Successful TKI Discontinuation in Chronic Myeloid Leukemia (CML) Patients: Preliminary Results of AST-Argentina Stop Trial

Carolina Pavlovsky, Ana Ines Varela, MD, Isolda I. Fernandez, MD, Maria Belen Sanchez, Maria Del Rosario Custidiano, MD, Josefina Freitas, MD, Veronica Ventriglia, MD, Ana Garcia de Labanca, MD, Georgina Bendek, MD, Romina Mariano, MD, Estrella Levy, PhD, Masiel Vera, Isabel Giere, PhD, Bianca Vasconcelos Cordoba, María Jose Mela Osorio, MD, Miguel A. Pavlovsky, MD, Julio Cesar Sanchez Avalos, MD, Cecilia Foncouberta, MD, Mariana Juni, Ms, Maximiliano Riddick, Michele Bianchini, PhD, Beatriz Moiraghi, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–5.
https://doi.org/10.1182/blood-2020-142416
Published: 2020
Journal Articles

In Pursuit of Surrogate Markers for Treatment-Free Remission in Patients with Chronic Myeloid Leukemia from Argentina Stop Trial

Maria Belen Sanchez, Beatriz Moiraghi, MD, Ana Ines Varela, MD, Estrella Levy, PhD, Masiel Vera, Bianca Vasconcelos Cordoba, Isabel Giere, PhD, Josefina Freitas, MD, Veronica Ventriglia, MD, Maria Del Rosario Custidiano, MD, Ana Garcia de Labanca, MD, Georgina Bendek, MD, Romina Mariano, MD, María Jose Mela Osorio, MD, Mariana Juni, Ms, Maximiliano Riddick, Miguel A. Pavlovsky, MD, Maria Cecilia Foncuberta, MD, Jose Mordoh, MD, Isolda I. Fernandez, MD, Julio Cesar Sanchez Avalos, MD, Carolina Pavlovsky, Michele Bianchini, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24.
https://doi.org/10.1182/blood-2020-141067
Published: 2020
Journal Articles

A Retrospective Multicenter Analysis of the Safety and Efficacy of Brentuximab Vedotin (BV) As Monotherapy or in Combination with Bendamustine (BV-B) in Relapsed Refractory Classic Hodgkin Lymphoma (cHL) in Argentina

Florencia Negri Aranguren, MD, Santiago Cranco, Claudia Shanley, MD, Isolda I. Fernandez, MD, Maria Virginia Prates, MD, Victoria Otero, Lorena Fiad, Maria Cecilia Foncuberta, MD, Marcela Miodosky, MD, Miguel A. Pavlovsky, MD, Gustavo Kuminsky, Javier Bordone, Bruno Wannesson, Ariel Corso Corso, Dardo Riveros, MD, Marisa Marquez, MD, Gustavo Jarchum, MD, Maria Sol Jarchum, Ider Ramon Cerutti, MD, Alicia Bistmas, Monica Tamashiro, MD, Giselda De Stefano, Alicia Navieckas, Silvana Cugliari, MD, Pedro Negri Aranguren, MD, Gabriela Balaguer, Maria Tosin, Guillermina Remaggi, Juan Altuve, Juan Jose Garcia, MD, Luciana C. Ferrari, MD, Graciela Klein, Luciana Guanchiale, Luis Beligoy, MD, Mariana Marull, Maria Cecilia Dacunto, Marta Elisa Zerga, MD, Nicolas Matias Kurgansky, MD, Marcelo Pujol, MD, Rossana L. Taus, MD PhD, Federico Sackman, MD PhD, Veronica Cintia Canosa, Soledad Cruset, Maximiliano Riddick, Astrid Pavlovsky, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4089.
https://doi.org/10.1182/blood.V130.Suppl_1.4089.4089
Published: 2017